Human tumor suppressor protein Pdcd4 binds at the mRNA entry channel in the 40S small ribosomal subunit.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 Aug 2024
Historique:
received: 28 12 2023
accepted: 17 07 2024
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 8 8 2024
Statut: epublish

Résumé

Translation is regulated mainly in the initiation step, and its dysregulation is implicated in many human diseases. Several proteins have been found to regulate translational initiation, including Pdcd4 (programmed cell death gene 4). Pdcd4 is a tumor suppressor protein that prevents cell growth, invasion, and metastasis. It is downregulated in most tumor cells, while global translation in the cell is upregulated. To understand the mechanisms underlying translational control by Pdcd4, we used single-particle cryo-electron microscopy to determine the structure of human Pdcd4 bound to 40S small ribosomal subunit, including Pdcd4-40S and Pdcd4-40S-eIF4A-eIF3-eIF1 complexes. The structures reveal the binding site of Pdcd4 at the mRNA entry site in the 40S, where the C-terminal domain (CTD) interacts with eIF4A at the mRNA entry site, while the N-terminal domain (NTD) is inserted into the mRNA channel and decoding site. The structures, together with quantitative binding and in vitro translation assays, shed light on the critical role of the NTD for the recruitment of Pdcd4 to the ribosomal complex and suggest a model whereby Pdcd4 blocks the eIF4F-independent role of eIF4A during recruitment and scanning of the 5' UTR of mRNA.

Identifiants

pubmed: 39117603
doi: 10.1038/s41467-024-50672-8
pii: 10.1038/s41467-024-50672-8
doi:

Substances chimiques

PDCD4 protein, human 0
RNA-Binding Proteins 0
Apoptosis Regulatory Proteins 0
RNA, Messenger 0
Eukaryotic Initiation Factor-4A EC 2.7.7.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6633

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM092927
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM152137
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Bhat, M. et al. Targeting the translation machinery in cancer. Nat. Rev. Drug Discov. 14, 261–278 (2015).
pubmed: 25743081 doi: 10.1038/nrd4505
Brito Querido, J., Díaz-López, I. & Ramakrishnan, V. The molecular basis of translation initiation and its regulation in eukaryotes. Nat. Rev. Mol. Cell Biol. https://doi.org/10.1038/s41580-023-00624-9 (2023).
Robichaud, N., Sonenberg, N., Ruggero, D. & Schneider, R. J. Translational control in cancer. Cold Spring Harb. Perspect. Biol. 11, a032896 (2019).
pubmed: 29959193 doi: 10.1101/cshperspect.a032896
Chang, J. H. et al. Crystal structure of the eIF4A-PDCD4 complex. Proc. Natl Acad. Sci. USA 106, 3148–3153 (2009).
pubmed: 19204291 doi: 10.1073/pnas.0808275106
Yang, H.-S. et al. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol. Cell Biol. 24, 3894–3906 (2004).
pubmed: 15082783 doi: 10.1128/MCB.24.9.3894-3906.2004
Suzuki, C. et al. PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. Proc. Natl Acad. Sci. USA 105, 3274–3279 (2008).
pubmed: 18296639 doi: 10.1073/pnas.0712235105
Waters, L. C. et al. Structure of the tandem MA-3 region of Pdcd4 protein and characterization of its interactions with eIF4A and eIF4G: molecular mechanisms of a tumor suppressor. J. Biol. Chem. 286, 17270–17280 (2011).
pubmed: 21454508 doi: 10.1074/jbc.M110.166157
Loh, P. G. et al. Structural basis for translational inhibition by the tumour suppressor Pdcd4. EMBO J. 28, 274–285 (2009).
pubmed: 19153607 doi: 10.1038/emboj.2008.278
Göke, A. et al. DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochem. Biophys. Res. Commun. 297, 78–82 (2002).
pubmed: 12220511 doi: 10.1016/S0006-291X(02)02129-0
Yang, H.-S. et al. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol. Cell Biol. 23, 26–37 (2003).
pubmed: 12482958 doi: 10.1128/MCB.23.1.26-37.2003
Böhm, M. et al. The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene 22, 4905–4910 (2003).
pubmed: 12894233 doi: 10.1038/sj.onc.1206710
Fehler, O. et al. An evolutionarily conserved interaction of tumor suppressor protein Pdcd4 with the poly(A)-binding protein contributes to translation suppression by Pdcd4. Nucleic Acids Res. 42, 11107–11118 (2014).
pubmed: 25190455 doi: 10.1093/nar/gku800
Singh, P., Wedeken, L., Waters, L. C., Carr, M. D. & Klempnauer, K.-H. Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation. Oncogene 30, 4864–4873 (2011).
pubmed: 21643008 doi: 10.1038/onc.2011.202
Wedeken, L., Ohnheiser, J., Hirschi, B., Wethkamp, N. & Klempnauer, K.-H. Association of tumor suppressor protein Pdcd4 with ribosomes is mediated by protein-protein and protein-RNA interactions. Genes Cancer 1, 293–301 (2010).
pubmed: 21779451 doi: 10.1177/1947601910364227
Itzhak, D. N., Tyanova, S., Cox, J. & Borner, G. H. Global, quantitative and dynamic mapping of protein subcellular localization. Elife 5, e16950 (2016).
pubmed: 27278775 doi: 10.7554/eLife.16950
Brito Querido, J. et al. The structure of a human translation initiation complex reveals two independent roles for the helicase eIF4A. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-023-01196-0 (2024).
Shuvalova, E. et al. Discovery of a novel role of tumor suppressor PDCD4 in stimulation of translation termination. J. Biol. Chem. 297, 101269 (2021).
pubmed: 34606825 doi: 10.1016/j.jbc.2021.101269
Leesch, F. et al. A molecular network of conserved factors keeps ribosomes dormant in the egg. Nature 613, 712–720 (2023).
pubmed: 36653451 doi: 10.1038/s41586-022-05623-y
Ben-Shem, A. et al. The structure of the eukaryotic ribosome at 3.0 Å resolution. Science 334, 1524–1529 (2011).
pubmed: 22096102 doi: 10.1126/science.1212642
Brown, A., Baird, M. R., Yip, M. C., Murray, J. & Shao, S. Structures of translationally inactive mammalian ribosomes. Elife 7, e40486 (2018).
pubmed: 30355441 doi: 10.7554/eLife.40486
Kišonaitė, M., Wild, K., Lapouge, K., Ruppert, T. & Sinning, I. High-resolution structures of a thermophilic eukaryotic 80S ribosome reveal atomistic details of translocation. Nat. Commun. 13, 476 (2022).
pubmed: 35079002 doi: 10.1038/s41467-022-27967-9
Zhao, Y., Rai, J., Yu, H. & Li, H. CryoEM structures of pseudouridine-free ribosome suggest impacts of chemical modifications on ribosome conformations. Structure 30, 983–992.e5 (2022).
pubmed: 35489333 doi: 10.1016/j.str.2022.04.002
Wells, J. N. et al. Structure and function of yeast Lso2 and human CCDC124 bound to hibernating ribosomes. PLoS Biol. 18, e3000780 (2020).
pubmed: 32687489 doi: 10.1371/journal.pbio.3000780
Simonetti, A., Guca, E., Bochler, A., Kuhn, L. & Hashem, Y. Structural insights into the mammalian late-stage initiation complexes. Cell Rep. 31, 107497 (2020).
pubmed: 32268096 doi: 10.1016/j.celrep.2020.03.061
Brito Querido, J. et al. Structure of a human 48S translational initiation complex. Science 369, 1220–1227 (2020).
pubmed: 32883864 doi: 10.1126/science.aba4904
Wang, Q. et al. Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma. Oncogene 36, 6225–6234 (2017).
pubmed: 28692058 doi: 10.1038/onc.2017.228
LaRonde-LeBlanc, N., Santhanam, A. N., Baker, A. R., Wlodawer, A. & Colburn, N. H. Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol. Cell Biol. 27, 147–156 (2007).
pubmed: 17060447 doi: 10.1128/MCB.00867-06
Bai, Y. et al. Pdcd4 is involved in the formation of stress granule in response to oxidized low-density lipoprotein or high-fat diet. PLoS ONE 11, e0159568 (2016).
pubmed: 27454120 doi: 10.1371/journal.pone.0159568
Kumar, S., Marriott, C. E., Alhasawi, N. F., Bone, A. J. & Macfarlane, W. M. The role of tumour suppressor PDCD4 in beta cell death in hypoxia. PLoS ONE 12, e0181235 (2017).
pubmed: 28750063 doi: 10.1371/journal.pone.0181235
Mm, F., Jm, C., Ka, U., Ma, P. & Ks, U. Enhanced arginine methylation of programmed cell death 4 protein during nutrient deprivation promotes tumor cell viability. J. Biol. Chem. 289, 17541–17552 (2014).
doi: 10.1074/jbc.M113.541300
Van Dyke, N., Chanchorn, E. & Van Dyke, M. W. The Saccharomyces cerevisiae protein Stm1p facilitates ribosome preservation during quiescence. Biochem. Biophys. Res. Commun. 430, 745–750 (2013).
pubmed: 23206692 doi: 10.1016/j.bbrc.2012.11.078
Biyanee, A., Ohnheiser, J., Singh, P. & Klempnauer, K.-H. A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: inhibition of translation elongation. Oncogene 34, 1384–1392 (2015).
pubmed: 24681950 doi: 10.1038/onc.2014.83
Ye, X. et al. Human tumor suppressor PDCD4 directly interacts with ribosomes to repress translation. Cell Res. https://doi.org/10.1038/s41422-024-00962-z (2024).
Lapointe, C. P. et al. eIF5B and eIF1A reorient initiator tRNA to allow ribosomal subunit joining. Nature 607, 185–190 (2022).
pubmed: 35732735 doi: 10.1038/s41586-022-04858-z
Sokabe, M. & Fraser, C. S. A helicase-independent activity of eIF4A in promoting mRNA recruitment to the human ribosome. Proc. Natl Acad. Sci. USA 114, 6304–6309 (2017).
pubmed: 28559306 doi: 10.1073/pnas.1620426114
Feoktistova, K., Tuvshintogs, E., Do, A. & Fraser, C. S. Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity. Proc. Natl Acad. Sci. USA 110, 13339–13344 (2013).
pubmed: 23901100 doi: 10.1073/pnas.1303781110
Sokabe, M. & Fraser, C. S. Human eukaryotic initiation factor 2 (eIF2)-GTP-Met-tRNAi ternary complex and eIF3 stabilize the 43 S preinitiation complex. J. Biol. Chem. 289, 31827–31836 (2014).
pubmed: 25246524 doi: 10.1074/jbc.M114.602870
Zeenko, V. V. et al. An efficient in vitro translation system from mammalian cells lacking the translational inhibition caused by eIF2 phosphorylation. RNA 14, 593–602 (2008).
pubmed: 18230759 doi: 10.1261/rna.825008
Russo, C. J., Scotcher, S. & Kyte, M. A precision cryostat design for manual and semi-automated cryo-plunge instruments. Rev. Sci. Instrum. 87, 114302 (2016).
pubmed: 27910462 doi: 10.1063/1.4967864
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, e42166 (2018).
pubmed: 30412051 doi: 10.7554/eLife.42166
Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216–221 (2015).
pubmed: 26278980 doi: 10.1016/j.jsb.2015.08.008
Kimanius, D. et al. Data-driven regularization lowers the size barrier of cryo-EM structure determination. Nat Methods 21, 1216–1221 (2024).
Casañal, A., Lohkamp, B. & Emsley, P. Current developments in coot for macromolecular model building of electron cryo-microscopy and crystallographic data. Protein Sci. https://doi.org/10.1002/pro.3791 (2019).
Jones, D. T. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 292, 195–202 (1999).
pubmed: 10493868 doi: 10.1006/jmbi.1999.3091
Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
pubmed: 15264254 doi: 10.1002/jcc.20084
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D Struct. Biol. 74, 531–544 (2018).
pubmed: 29872004 doi: 10.1107/S2059798318006551
Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018).
pubmed: 28710774 doi: 10.1002/pro.3235
Kratzat, H. et al. A structural inventory of native ribosomal ABCE1-43S pre-initiation complexes. EMBO J. https://doi.org/10.15252/embj.2020105179 (2020).

Auteurs

Jailson Brito Querido (J)

MRC Laboratory of Molecular Biology, Cambridge, UK. jquerido@umich.edu.
Department of Biological Chemistry, University of Michigan, Ann Arbor, MI, USA. jquerido@umich.edu.
Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA. jquerido@umich.edu.
Center for RNA Biomedicine, University of Michigan, Ann Arbor, MI, USA. jquerido@umich.edu.

Masaaki Sokabe (M)

Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, CA, USA.

Irene Díaz-López (I)

MRC Laboratory of Molecular Biology, Cambridge, UK.

Yuliya Gordiyenko (Y)

MRC Laboratory of Molecular Biology, Cambridge, UK.

Philipp Zuber (P)

MRC Laboratory of Molecular Biology, Cambridge, UK.

Yifei Du (Y)

MRC Laboratory of Molecular Biology, Cambridge, UK.

Lucas Albacete-Albacete (L)

MRC Laboratory of Molecular Biology, Cambridge, UK.

V Ramakrishnan (V)

MRC Laboratory of Molecular Biology, Cambridge, UK. ramak@mrc-lmb.cam.ac.uk.

Christopher S Fraser (CS)

Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, CA, USA. csfraser@ucdavis.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH